Lenalidomide downregulates the production of IL-6 directly and also by inhibiting multiple myeloma (MM) cells and bone marrow stromal cells (BMSC) interaction [11,12], which augments the apoptosis of myeloma cells[13]. Here, IL6 is linked to plasma cell myeloma.